ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
139 hedge funds and large institutions have $331M invested in Intercept Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 50 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
38% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 50
Holders
139
Holding in Top 10
–
Calls
$17M
Puts
$23.2M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$7.82M | |
| 3 | +$5.2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.85M |
| 5 |
Renaissance Technologies
New York
|
+$3.19M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$8.69M | |
| 3 | -$6.43M | |
| 4 |
PP
PDT Partners
New York
|
-$2.29M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.86M |